Lista de obras - Massimo Iavarone - Dominio Público Uruguay

A cell culture system for distinguishing hepatitis C viruses with and without liver cancer-related mutations in the viral core gene.

artículo científico publicado en 2015

A genomic and clinical prognostic index for hepatitis C-related early-stage cirrhosis that predicts clinical deterioration

artículo científico publicado en 2014

A hepatic stellate cell gene expression signature associated with outcomes in hepatitis C cirrhosis and hepatocellular carcinoma after curative resection

artículo científico publicado en 2015

A prospective study of blood alpha-fetoprotein messenger RNA as a predictor of hepatocellular carcinoma in patients with cirrhosis.

artículo científico publicado en 2003

Adefovir rapidly suppresses hepatitis B in HBeAg-negative patients developing genotypic resistance to lamivudine.

artículo científico publicado en 2005

Changing aetiological factors of hepatocellular carcinoma and their potential impact on the effectiveness of surveillance

scientific article published on 01 November 2011

Characterisation of hepatitis B virus X protein mutants in tumour and non-tumour liver cells using laser capture microdissection.

artículo científico publicado en 2003

Cholangiocarcinoma in Cirrhosis: Value of Hepatocyte Specific Magnetic Resonance Imaging

scientific article published on 21 October 2015

Clinical features and outcomes of hepatocellular carcinoma in Caucasian cirrhotic patients on long-term analogue therapy for hepatitis B

artículo científico publicado en 2018

Combination of CLIF-OF and CCI predicts survival in patients with cirrhosis and COVID-19

artículo científico publicado en 2020

Contrast enhanced CT-scan to diagnose intrahepatic cholangiocarcinoma in patients with cirrhosis.

artículo científico publicado en 2013

Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules.

artículo científico publicado en 2017

Determinants of esophageal varices bleeding in patients with advanced hepatocellular carcinoma treated with sorafenib.

artículo científico publicado en 2015

Diagnosis of hepatocellular carcinoma in cirrhosis by dynamic contrast imaging: the importance of tumor cell differentiation.

artículo científico publicado en 2010

Diagnostic accuracy of clathrin heavy chain staining in a marker panel for the diagnosis of small hepatocellular carcinoma

scientific article published on 01 May 2011

Early diagnosis of liver cancer: an appraisal of international recommendations and future perspectives.

artículo científico

Extended survival of patients with persistently suppressed hepatitis B transplanted for hepatocellular carcinoma.

artículo científico publicado en 2015

Factors Associated With Increased Risk of De Novo or Recurrent Hepatocellular Carcinoma in Patients With Cirrhosis Treated With Direct-Acting Antivirals for HCV Infection

artículo científico publicado en 2018

Field-practice study of sorafenib therapy for hepatocellular carcinoma: A prospective multicenter study in Italy

article

HBV Infection and Hepatocellular Carcinoma ⬇️

artículo científico publicado el 3 de julio de 2013

HBV-related HCC, clinical issues and therapy

artículo científico publicado en 2011

Hepatic fat - genetic risk score predicts hepatocellular carcinoma in HCV cirrhotic patients treated with DAAs

artículo científico publicado en 2020

Hepatitis C virus genotype 1b, cirrhosis, and risk of hepatocellular carcinoma.

artículo científico publicado en 2008

High isavuconazole plasma levels in a patient with possible invasive pulmonary aspergillosis and cirrhosis.

artículo científico publicado en 2018

Imaging of combined hepatocellular-cholangiocarcinoma in cirrhosis and risk of false diagnosis of hepatocellular carcinoma

scientific article published on 22 November 2018

Improved survival of patients with hepatocellular carcinoma and compensated hepatitis C virus-related cirrhosis who attained sustained virological response.

artículo científico publicado en 2017

Increased expression of vascular endothelial growth factor in small hepatocellular carcinoma.

artículo científico publicado en 2007

Interferon-free therapy of hepatitis C during wait list and post-transplant risk of hepatocellular carcinoma recurrence

artículo científico publicado en 2017

Liver Transplantations and Brain Dead Donors With Alcohol Abuse

artículo científico publicado en 2018

Liver transplant for hepatocellular carcinoma: A heavyweight therapeutic option in need of a new policy on liver graft allocation

scientific article published on 27 September 2018

Low resistance to adefovir combined with lamivudine: a 3-year study of 145 lamivudine-resistant hepatitis B patients.

artículo científico publicado en 2007

Minimal increases of serum alpha-foetoprotein herald HCC detection in Caucasian HBV cirrhotic patients under long-term oral therapy

scientific article published on 12 August 2019

Molecular Liver Cancer Prevention in Cirrhosis by Organ Transcriptome Analysis and Lysophosphatidic Acid Pathway Inhibition

artículo científico publicado en 2016

Multimodality treatment of hepatocellular carcinoma: How field practice complies with international recommendations

artículo científico publicado en 2018

Overview of Immune Checkpoint Inhibitors Therapy for Hepatocellular Carcinoma, and The ITA.LI.CA Cohort Derived Estimate of Amenability Rate to Immune Checkpoint Inhibitors in Clinical Practice

artículo científico publicado en 2019

PNPLA3 I148M polymorphism, clinical presentation, and survival in patients with hepatocellular carcinoma

artículo científico publicado en 2013

Patterns of appearance and risk of misdiagnosis of intrahepatic cholangiocarcinoma in cirrhosis at contrast enhanced ultrasound.

artículo científico publicado en 2013

Predictors of survival in patients with advanced hepatocellular carcinoma who permanently discontinued sorafenib.

artículo científico publicado en 2015

Preliminary experience on safety of regorafenib after sorafenib failure in recurrent hepatocellular carcinoma after liver transplantation

artículo científico publicado en 2019

Prognostic ability of BCLC-B Subclassification in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization.

artículo científico publicado en 2017

Prognostic gene expression signature for patients with hepatitis C-related early-stage cirrhosis

artículo científico publicado en 2013

Re: Indeterminate 1-2 Cm Nodules Found on Hepatocellular Carcinoma Surveillance: Biopsy for All, Some, or None? ⬇️

artículo científico publicado el 1 de febrero de 2012

Reply to: “Non-invasive diagnosis of small nodules in cirrhosis” ⬇️

artículo científico publicado el 16 de agosto de 2013

Risk of hepatocellular carcinoma in relation to ABO blood type

artículo científico publicado en 2015

Role of antiviral treatment for HCC prevention.

artículo científico

Sarcopenia is associated with reduced survival in patients with advanced hepatocellular carcinoma undergoing sorafenib treatment

artículo científico publicado en 2018

Second line systemic therapies for hepatocellular carcinoma: Reasons for the failure

artículo científico publicado en 2015

Severe cholestatic hepatitis related to abacavir/lamivudine/dolutegravir antiretroviral treatment in a HIV-1 infected subject

scientific article published on 01 July 2018

Sorafenib-Induced Destructive Thyroiditis ⬇️

artículo científico publicado el 1 de septiembre de 2010

Survival of patients with HCV cirrhosis and sustained virologic response is similar to the general population

artículo científico publicado en 2016

The clinical and pathogenetic significance of estrogen receptor-beta expression in chronic liver diseases and liver carcinoma.

artículo científico publicado en 2003

The combination of PIVKA-II and AFP improves the detection accuracy for HCC in HBV Caucasian cirrhotics on long-term oral therapy

scientific article published on 16 April 2020

The long-term benefits of nucleos(t)ide analogs in compensated HBV cirrhotic patients with no or small esophageal varices: A 12-year prospective cohort study

artículo científico publicado en 2015

Transarterial chemoembolization with drug-eluting beads is effective for the maintenance of the Milan-in status in patients with a small hepatocellular carcinoma.

artículo científico publicado en 2015

Transarterial embolization with microspheres in the treatment of monofocal HCC.

artículo científico publicado en 2008

Uncommon extrahepatic metastases from hepatocellular carcinoma.

artículo científico publicado en 2017

VEGF and VEGFR genotyping in the prediction of clinical outcome for HCC patients receiving sorafenib: the ALICE-1 study

scientific article published on 20 February 2014

eNOS polymorphisms and clinical outcome in advanced HCC patients receiving sorafenib: final results of the ePHAS study

scientific article published on 04 April 2016

Lista de obras de Massimo Iavarone

A cell culture system for distinguishing hepatitis C viruses with and without liver cancer-related mutations in the viral core gene.

A genomic and clinical prognostic index for hepatitis C-related early-stage cirrhosis that predicts clinical deterioration

A hepatic stellate cell gene expression signature associated with outcomes in hepatitis C cirrhosis and hepatocellular carcinoma after curative resection

A prospective study of blood alpha-fetoprotein messenger RNA as a predictor of hepatocellular carcinoma in patients with cirrhosis.

Adefovir rapidly suppresses hepatitis B in HBeAg-negative patients developing genotypic resistance to lamivudine.

Changing aetiological factors of hepatocellular carcinoma and their potential impact on the effectiveness of surveillance

Characterisation of hepatitis B virus X protein mutants in tumour and non-tumour liver cells using laser capture microdissection.

Cholangiocarcinoma in Cirrhosis: Value of Hepatocyte Specific Magnetic Resonance Imaging

Clinical features and outcomes of hepatocellular carcinoma in Caucasian cirrhotic patients on long-term analogue therapy for hepatitis B

Combination of CLIF-OF and CCI predicts survival in patients with cirrhosis and COVID-19

Contrast enhanced CT-scan to diagnose intrahepatic cholangiocarcinoma in patients with cirrhosis.

Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules.

Determinants of esophageal varices bleeding in patients with advanced hepatocellular carcinoma treated with sorafenib.

Diagnosis of hepatocellular carcinoma in cirrhosis by dynamic contrast imaging: the importance of tumor cell differentiation.

Diagnostic accuracy of clathrin heavy chain staining in a marker panel for the diagnosis of small hepatocellular carcinoma

Early diagnosis of liver cancer: an appraisal of international recommendations and future perspectives.

Extended survival of patients with persistently suppressed hepatitis B transplanted for hepatocellular carcinoma.

Factors Associated With Increased Risk of De Novo or Recurrent Hepatocellular Carcinoma in Patients With Cirrhosis Treated With Direct-Acting Antivirals for HCV Infection

Field-practice study of sorafenib therapy for hepatocellular carcinoma: A prospective multicenter study in Italy

HBV Infection and Hepatocellular Carcinoma ⬇️

HBV-related HCC, clinical issues and therapy

Hepatic fat - genetic risk score predicts hepatocellular carcinoma in HCV cirrhotic patients treated with DAAs

Hepatitis C virus genotype 1b, cirrhosis, and risk of hepatocellular carcinoma.

High isavuconazole plasma levels in a patient with possible invasive pulmonary aspergillosis and cirrhosis.

Imaging of combined hepatocellular-cholangiocarcinoma in cirrhosis and risk of false diagnosis of hepatocellular carcinoma

Improved survival of patients with hepatocellular carcinoma and compensated hepatitis C virus-related cirrhosis who attained sustained virological response.

Increased expression of vascular endothelial growth factor in small hepatocellular carcinoma.

Interferon-free therapy of hepatitis C during wait list and post-transplant risk of hepatocellular carcinoma recurrence

Liver Transplantations and Brain Dead Donors With Alcohol Abuse

Liver transplant for hepatocellular carcinoma: A heavyweight therapeutic option in need of a new policy on liver graft allocation

Low resistance to adefovir combined with lamivudine: a 3-year study of 145 lamivudine-resistant hepatitis B patients.

Minimal increases of serum alpha-foetoprotein herald HCC detection in Caucasian HBV cirrhotic patients under long-term oral therapy

Molecular Liver Cancer Prevention in Cirrhosis by Organ Transcriptome Analysis and Lysophosphatidic Acid Pathway Inhibition

Multimodality treatment of hepatocellular carcinoma: How field practice complies with international recommendations

Overview of Immune Checkpoint Inhibitors Therapy for Hepatocellular Carcinoma, and The ITA.LI.CA Cohort Derived Estimate of Amenability Rate to Immune Checkpoint Inhibitors in Clinical Practice

PNPLA3 I148M polymorphism, clinical presentation, and survival in patients with hepatocellular carcinoma

Patterns of appearance and risk of misdiagnosis of intrahepatic cholangiocarcinoma in cirrhosis at contrast enhanced ultrasound.

Predictors of survival in patients with advanced hepatocellular carcinoma who permanently discontinued sorafenib.

Preliminary experience on safety of regorafenib after sorafenib failure in recurrent hepatocellular carcinoma after liver transplantation

Prognostic ability of BCLC-B Subclassification in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization.

Prognostic gene expression signature for patients with hepatitis C-related early-stage cirrhosis

Re: Indeterminate 1-2 Cm Nodules Found on Hepatocellular Carcinoma Surveillance: Biopsy for All, Some, or None? ⬇️

Reply to: “Non-invasive diagnosis of small nodules in cirrhosis” ⬇️

Risk of hepatocellular carcinoma in relation to ABO blood type

Role of antiviral treatment for HCC prevention.

Sarcopenia is associated with reduced survival in patients with advanced hepatocellular carcinoma undergoing sorafenib treatment

Second line systemic therapies for hepatocellular carcinoma: Reasons for the failure

Severe cholestatic hepatitis related to abacavir/lamivudine/dolutegravir antiretroviral treatment in a HIV-1 infected subject

Sorafenib-Induced Destructive Thyroiditis ⬇️

Survival of patients with HCV cirrhosis and sustained virologic response is similar to the general population

The clinical and pathogenetic significance of estrogen receptor-beta expression in chronic liver diseases and liver carcinoma.

The combination of PIVKA-II and AFP improves the detection accuracy for HCC in HBV Caucasian cirrhotics on long-term oral therapy

The long-term benefits of nucleos(t)ide analogs in compensated HBV cirrhotic patients with no or small esophageal varices: A 12-year prospective cohort study

Transarterial chemoembolization with drug-eluting beads is effective for the maintenance of the Milan-in status in patients with a small hepatocellular carcinoma.

Transarterial embolization with microspheres in the treatment of monofocal HCC.

Uncommon extrahepatic metastases from hepatocellular carcinoma.

VEGF and VEGFR genotyping in the prediction of clinical outcome for HCC patients receiving sorafenib: the ALICE-1 study

eNOS polymorphisms and clinical outcome in advanced HCC patients receiving sorafenib: final results of the ePHAS study